Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1988 Jul;85(13):4889–4893. doi: 10.1073/pnas.85.13.4889

Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats.

H P Guler 1, J Zapf 1, E Scheiwiller 1, E R Froesch 1
PMCID: PMC280542  PMID: 3387445

Abstract

Recombinant human insulin-like growth factor I (rhIGF-I) was infused subcutaneously into hypophysectomized rats for as long as 18 days. Three hundred micrograms (39 nmol) of rhIGF-I per day and 200 milliunits (4.5 nmol) of human growth hormone (hGH) per day increased body weight, tibial epiphyseal width, longitudinal bone growth, and trabecular bone formation similarly. Weight gains of the kidneys and spleen, however, were greater with rhIGF-I than with hGH, whereas the weight of the epididymal fat pads was reduced with rhIGF-I. The weight of the thymus was increased by rhIGF-I treatment. Thus, IGF-I administered over a prolonged period of time mimics GH effects in hypophysectomized rats. Quantitative differences between rhIGF-I and hGH treatment with respect to organ weights may be related to different forms of circulating IGF-I or may be due to independent effects of GH and IGF-I. The results support the somatomedin hypothesis, but they also stress the role of GH as a modulator of IGF-I action.

Full text

PDF
4889

Images in this article

4891Image
on p.4891
4891Image
on p.4891
4891Image
on p.4891
4891Image
on p.4891
4891Image
on p.4891
4891Image
on p.4891

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Clemmons D. R., Underwood L. E., Van Wyk J. J. Hormonal control of immunoreactive somatomedin production by cultured human fibroblasts. J Clin Invest. 1981 Jan;67(1):10–19. doi: 10.1172/JCI110001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Daughaday W. H., Hall K., Raben M. S., Salmon W. D., Jr, van den Brande J. L., van Wyk J. J. Somatomedin: proposed designation for sulphation factor. Nature. 1972 Jan 14;235(5333):107–107. doi: 10.1038/235107a0. [DOI] [PubMed] [Google Scholar]
  3. Froesch E. R., Schmid C., Schwander J., Zapf J. Actions of insulin-like growth factors. Annu Rev Physiol. 1985;47:443–467. doi: 10.1146/annurev.ph.47.030185.002303. [DOI] [PubMed] [Google Scholar]
  4. GREENSPAN F. S., LI C. H. Bioassay of hypophyseal growth hormone; the tibia test. Endocrinology. 1949 Nov;45(5):455-63, illust. doi: 10.1210/endo-45-5-455. [DOI] [PubMed] [Google Scholar]
  5. Guler H. P., Zapf J., Froesch E. R. Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med. 1987 Jul 16;317(3):137–140. doi: 10.1056/NEJM198707163170303. [DOI] [PubMed] [Google Scholar]
  6. Hansson L. I., Menander-Sellman K., Stenström A., Thorngren K. G. Rate of normal longitudinal bone growth in the rat. Calcif Tissue Res. 1972;10(3):238–251. doi: 10.1007/BF02012553. [DOI] [PubMed] [Google Scholar]
  7. Isaksson O. G., Edén S., Jansson J. O. Mode of action of pituitary growth hormone on target cells. Annu Rev Physiol. 1985;47:483–499. doi: 10.1146/annurev.ph.47.030185.002411. [DOI] [PubMed] [Google Scholar]
  8. Isgaard J., Nilsson A., Lindahl A., Jansson J. O., Isaksson O. G. Effects of local administration of GH and IGF-1 on longitudinal bone growth in rats. Am J Physiol. 1986 Apr;250(4 Pt 1):E367–E372. doi: 10.1152/ajpendo.1986.250.4.E367. [DOI] [PubMed] [Google Scholar]
  9. Kurtz A., Jelkmann W., Bauer C. A new candidate for the regulation of erythropoiesis. Insulin-like growth factor I. FEBS Lett. 1982 Nov 22;149(1):105–108. doi: 10.1016/0014-5793(82)81081-8. [DOI] [PubMed] [Google Scholar]
  10. Morikawa M., Nixon T., Green H. Growth hormone and the adipose conversion of 3T3 cells. Cell. 1982 Jul;29(3):783–789. doi: 10.1016/0092-8674(82)90440-8. [DOI] [PubMed] [Google Scholar]
  11. Nagy E., Berczi I., Friesen H. G. Regulation of immunity in rats by lactogenic and growth hormones. Acta Endocrinol (Copenh) 1983 Mar;102(3):351–357. doi: 10.1530/acta.0.1020351. [DOI] [PubMed] [Google Scholar]
  12. Nagy E., Berczi I. Immunodeficiency in hypophysectomized rats. Acta Endocrinol (Copenh) 1978 Nov;89(3):530–537. doi: 10.1530/acta.0.0890530. [DOI] [PubMed] [Google Scholar]
  13. Nixon B. T., Green H. Growth hormone promotes the differentiation of myoblasts and preadipocytes generated by azacytidine treatment of 10T1/2 cells. Proc Natl Acad Sci U S A. 1984 Jun;81(11):3429–3432. doi: 10.1073/pnas.81.11.3429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Pandian M. R., Talwar G. P. Effect of growth hormone on the metabolism of thymus and on the immune response against sheep erythrocytes. J Exp Med. 1971 Nov 1;134(5):1095–1113. doi: 10.1084/jem.134.5.1095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Scheiwiller E., Guler H. P., Merryweather J., Scandella C., Maerki W., Zapf J., Froesch E. R. Growth restoration of insulin-deficient diabetic rats by recombinant human insulin-like growth factor I. Nature. 1986 Sep 11;323(6084):169–171. doi: 10.1038/323169a0. [DOI] [PubMed] [Google Scholar]
  16. Schoenle E., Zapf J., Hauri C., Steiner T., Froesch E. R. Comparison of in vivo effects of insulin-like growth factors I and II and of growth hormone in hypophysectomized rats. Acta Endocrinol (Copenh) 1985 Feb;108(2):167–174. doi: 10.1530/acta.0.1080167. [DOI] [PubMed] [Google Scholar]
  17. Schoenle E., Zapf J., Humbel R. E., Froesch E. R. Insulin-like growth factor I stimulates growth in hypophysectomized rats. Nature. 1982 Mar 18;296(5854):252–253. doi: 10.1038/296252a0. [DOI] [PubMed] [Google Scholar]
  18. Underwood L. E., D'Ercole A. J., Clemmons D. R., Van Wyk J. J. Paracrine functions of somatomedins. Clin Endocrinol Metab. 1986 Feb;15(1):59–77. doi: 10.1016/s0300-595x(86)80042-1. [DOI] [PubMed] [Google Scholar]
  19. Zapf J., Walter H., Froesch E. R. Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia. J Clin Invest. 1981 Nov;68(5):1321–1330. doi: 10.1172/JCI110379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Zezulak K. M., Green H. The generation of insulin-like growth factor-1--sensitive cells by growth hormone action. Science. 1986 Aug 1;233(4763):551–553. doi: 10.1126/science.3726546. [DOI] [PubMed] [Google Scholar]
  21. van Buul-Offers S., Ueda I., Van den Brande J. L. Biosynthetic somatomedin C (SM-C/IGF-I) increases the length and weight of Snell dwarf mice. Pediatr Res. 1986 Sep;20(9):825–827. doi: 10.1203/00006450-198609000-00002. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES